Stock Events

Stock Events

GSK 

ARS20,280.00
11892
-ARS10.00-0.05%Tuesday 20:44

Statistics

Day High
20,370
Day Low
20,280
52W High
22,760
52W Low
17,010
Volume
80
Avg. Volume
1,083
Mkt Cap
40.63T
P/E Ratio
25.25
Dividend Yield
6.98%
Dividend
1,414.84

Upcoming

Dividends

6.98%Dividend Yield
Oct 2026
ARS341.10
Jul 2026
ARS339.18
Apr 2026
ARS334.13
Jan 2026
ARS314.60
Oct 2025
ARS302.50
10Y Growth
-4.03%
5Y Growth
-7.42%
3Y Growth
7.01%
1Y Growth
7.94%

Earnings

Feb 3Expected
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Next
0.32
0.46
0.6
0.74
Expected EPS
0.3745824084
Actual EPS
N/A

Financials

-0.75%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
56.31TRevenue
-424.74BNet Income

Analyst Ratings

$214.28Average Price Target
The highest estimate is ⁦214.28⁩.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GSK.BA. It's not an investment recommendation.
Legal & General Group
3246
LGEN.LSE
BP
2674
BP.LSE
National Grid
2482
NG.LSE
Aviva
2191
AV.LSE

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap173.95B
Pfizer is a direct competitor in the pharmaceuticals sector, competing in various therapeutic areas including vaccines.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson competes with GSK in both pharmaceuticals and consumer health products.
Merck
MRK
Mkt Cap368.89B
Merck & Co. is a competitor in the pharmaceuticals industry, with a strong presence in vaccines and cancer treatments.
Novartis
NVS
Mkt Cap303.67B
Novartis competes with GSK in multiple areas including respiratory and neuroscience.
Abbvie
ABBV
Mkt Cap521.11B
AbbVie competes in the biopharmaceutical sector, with overlap in immunology and oncology areas.
Sanofi
SNY
Mkt Cap106.24B
Sanofi competes directly with GSK in the vaccines market and other pharmaceutical areas.
Astrazeneca
AZN
Mkt Cap289.48B
AstraZeneca competes in various pharmaceutical areas including respiratory, cardiovascular, and oncology, similar to GSK.
Bristol-Myers Squibb
BMY
Mkt Cap127.71B
Bristol Myers Squibb competes in the pharmaceutical sector, particularly in cancer and cardiovascular diseases.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG competes in pharmaceuticals and diagnostics, with a strong focus on oncology and immunology.
AMGEN
AMGN
Mkt Cap251.94B
Amgen competes in the biotech sector, with products that overlap with GSK’s offerings in areas like bone health and oncology.

About

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Show More
CEO
Luke Victor Miels
Employees
66841
Country
United Kingdom
ISIN
ARDEUT110483

Listings

MX
MX
GSKN.MX
MX
MX
GSK1N.MX
XETRA
DE
GS71.XETRA
STU
DE
GS71.STU

0 Comments

Share your thoughts

FAQs

What is GSK stock price today?▼
The current price of GSK.BA is ARS20,280.00 ARS — it has decreased by -0.05% in the past 24 hours. Watch GSK stock price performance more closely on the chart.
What is GSK stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Buenos Aires Exchange exchange GSK stocks are traded under the ticker GSK.BA.
Is GSK stock price growing?▼
GSK.BA stock has risen by +0.7% compared to the previous week, the month change is a +6.35% rise, over the last year GSK has showed a +14.71% increase.
What is GSK market cap?▼
Today GSK has the market capitalization of 40.63T
When is the next GSK earnings date?▼
GSK is going to release the next earnings report on February 3, 2027.
What were GSK earnings last quarter?▼
GSK.BA earnings for the last quarter are 1,116.31 ARS per share, whereas the estimation was 1,029.24 ARS resulting in a +8.46% surprise. The estimated earnings for the next quarter are N/A ARS per share.
What is GSK revenue for the last year?▼
GSK revenue for the last year amounts to 56.31T ARS.
What is GSK net income for the last year?▼
GSK.BA net income for the last year is -424.74B ARS.
Does GSK pay dividends?▼
Yes, GSK.BA dividends are paid quarterly. The last dividend per share was 170.66 . As of today, Dividend Yield (FWD)% is 6.98%.
How many employees does GSK have?▼
As of November 4, 2026, the company has 66,841 employees.
In which sector is GSK located?▼
GSK operates in the Health & Wellness sector.
When did GSK complete a stock split?▼
The last stock split for GSK was on July 19, 2022 with a ratio of 4:5.
Where is GSK headquartered?▼
GSK is headquartered in London, United Kingdom.